Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer - Wikidata - awgldk - TriplyDB

Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer

Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer

http://www.wikidata.org/entity/Q35147520

about

Local Ablative Strategies for Ductal Pancreatic Cancer (Radiofrequency Ablation, Irreversible Electroporation): A Review Current therapeutic strategies for advanced pancreatic cancer: A review for clinicians Pancreatic cancer surgery: past, present, and future Neoadjuvant therapy for localized pancreatic cancer: guiding principles Systematic Review of Resection Rates and Clinical Outcomes After FOLFIRINOX-Based Treatment in Patients with Locally Advanced Pancreatic Cancer Cattell-Braasch maneuver combined with local hypothermia during superior mesenteric artery resection in pancreatectomy Neoadjuvant chemotherapy in borderline resectable pancreatic cancer: A case report.Neoadjuvant chemotherapy for pancreatic cancer: Effects on cancer tissue and novel perspectives.Chemotherapy and tumor microenvironment of pancreatic cancer.Objective Assessment of Surgical Restaging after Concurrent Chemoradiation for Locally Advanced Pancreatic Cancer.The proteome of postsurgical pancreatic juice.Meta-analysis of benefits of portal-superior mesenteric vein resection in pancreatic resection for ductal adenocarcinoma.Complete pathological response following neoadjuvant FOLFIRINOX in borderline resectable pancreatic cancer - a case report and review Inverse Probability of Treatment Weighting Analysis of Upfront Surgery Versus Neoadjuvant Chemoradiotherapy Followed by Surgery for Pancreatic Adenocarcinoma with Arterial Abutment.Health Insurance Expansion and Treatment of Pancreatic Cancer: Does Increased Access Lead to Improved Care?Meta-analyses of treatment standards for pancreatic cancer.A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma FOLFIRINOX Induction Therapy for Stage 3 Pancreatic Adenocarcinoma FOLFIRINOX in Locally Advanced and Metastatic Pancreatic Cancer: A Single Centre Cohort Study.Robotic and open distal pancreatectomy with celiac axis resection for locally advanced pancreatic body tumors: a single institutional assessment of perioperative outcomes and survival.Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101.Should every patient with pancreatic cancer receive perioperative/neoadjuvant therapy?Complete Response after Treatment with Neoadjuvant Chemoradiation with Prolonged Chemotherapy for Locally Advanced, Unresectable Adenocarcinoma of the Pancreas.Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) - study protocol for a national multicentre randomized controlled trial.Induction Chemotherapy with Gemcitabine and Cisplatin Followed by Simultaneous Integrated Boost-Intensity Modulated Radiotherapy with Concurrent Gemcitabine for Locally Advanced Unresectable Pancreatic Cancer: Results from a Feasibility Study.Surgical resection strategies for locally advanced pancreatic cancer.Artery first approach to pancreatoduodenectomy: current status.Pathologic Major Response After FOLFIRINOX is Prognostic for Patients Secondary Resected for Borderline or Locally Advanced Pancreatic Adenocarcinoma: An AGEO-FRENCH, Prospective, Multicentric Cohort.Recent Advances in Pancreatic Cancer Surgery.Current status on the place of FOLFIRINOX in metastatic pancreatic cancer and future directions.Reappraisal of Staging Laparoscopy for Patients with Pancreatic Adenocarcinoma: A Contemporary Analysis of 1001 Patients.Multiagent induction chemotherapy followed by chemoradiation is associated with improved survival in locally advanced pancreatic cancer.The role of neoadjuvant therapy in pancreatic cancer: a review.Histopathologic tumor invasion of superior mesenteric vein/ portal vein is a poor prognostic indicator in patients with pancreatic ductal adenocarcinoma: results from a systematic review and meta-analysis.FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis.Borderline resectable pancreatic cancer: conceptual evolution and current approach to image-based classification.Preoperative FOLFIRINOX for borderline resectable pancreatic cancer: Is radiation necessary in the modern era of chemotherapy?Is resection of pancreatic adenocarcinoma with synchronous hepatic metastasis justified? A review of current literature.A Graded Evaluation of Outcomes Following Pancreaticoduodenectomy with Major Vascular Resection in Pancreatic Cancer.Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy.

P2860

Q26765288-9A287351-5000-4E58-B878-208460A5015B Q26767041-4E2FD9F7-BB4A-4475-8D16-D3331C04BB79 Q26781555-2FED5232-C55D-4E11-8CEA-37E30BBF4F3A Q26799428-0F467942-503D-41D9-9C37-0E0D24429A3E Q28072210-EBB26F3E-688E-43F5-9FED-3AA0169942DD Q28588816-55DBF264-C1E8-44B7-B0F6-3D2A8D44C666 Q33750803-2576F69E-CA87-4585-908B-AE76ECE65733 Q33751263-6A2C8F2C-F56D-4691-922F-D9460648E349 Q33876637-AF9D359E-892E-4E7B-9DF8-72E7DE363C82 Q35778600-9BB346D6-987D-4E99-BF05-713684E84493 Q35864160-4607DBFA-0A12-4902-98BF-59EFEA0CDE35 Q35867892-2724CDCE-4C90-49EE-84D0-EA43FF79AF90 Q36159880-72A9A9D1-F7E9-4180-BE68-5A8C71D624DD Q36195812-1AAFBA69-05DB-4C32-9C1E-3A37CE557F92 Q36327297-452BCE0A-8CB1-4B5C-8D09-B42BA2D40592 Q36640493-6958F034-7CCE-483D-B189-DDE9295D4D3E Q36848514-51D00ECD-965A-4DD8-A42C-D9C2C4CE9D77 Q36848552-BF4945F1-839F-4FEA-96AD-6567E6437336 Q37290494-042FB6B8-36B4-44DE-8176-EE2EB2A64F01 Q37331861-F325DC48-013F-4D29-A904-9F497D006BD9 Q37555302-6A3EFDC8-309F-4FCF-9EFE-CE5AF5E0188D Q37584906-2F58B7D1-A1DF-4410-BBAC-28813ED776C8 Q37714700-CFD2B59B-AFBF-4DBA-90C2-92C7F72F0158 Q38371662-0D0A33E1-BB88-4318-89E4-98D009DD1A37 Q38406521-961127C8-FE5D-460A-8764-8D0CF2A045A3 Q38538721-144941DB-2860-46AB-AA65-44D930EA8851 Q38561432-E731E2B2-F992-45A3-A781-46A7D4DE6655 Q38566193-60669E27-6929-40BA-BE00-F8809E5E9148 Q38602630-1DEBFA86-3F53-4569-A463-0CB5A2C71C3B Q38637958-1CBEDD00-FA1A-4287-AFFA-095369087EAF Q38674441-64DEDC7D-0B2F-432C-ACD6-2E8DBF9E8753 Q38722475-1B0F3D43-631A-4E70-8022-124E106810B3 Q38734981-B2768021-15F5-482A-A50C-8768E4A0783C Q38828303-B2223C24-F2EF-46FE-AEA9-62F4FE04EAEE Q38829982-90774E73-32E2-481C-8669-BC0B6A71C2CF Q38838295-B0839319-3A96-4791-A82F-E0B6DB2EE42E Q38905077-D15934F1-D7A1-4FE7-A295-4B292E4B9FDA Q38942566-488216CF-7237-448F-9D94-72374BEB1929 Q38950663-B1DE8055-FDC0-405B-9EA0-35AC598456D7 Q38954668-126EB7CB-CFE5-4B92-BACC-16FDBDEB93A3

P2860

Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer

http://www.wikidata.org/entity/Q35147520

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Radiological and surgical impl ...... e resectable pancreatic cancer

@ast

Radiological and surgical impl ...... e resectable pancreatic cancer

@en

type

label

Radiological and surgical impl ...... e resectable pancreatic cancer

@ast

Radiological and surgical impl ...... e resectable pancreatic cancer

@en

prefLabel

Radiological and surgical impl ...... e resectable pancreatic cancer

@ast

Radiological and surgical impl ...... e resectable pancreatic cancer

@en

P1433

Q35147520-035A1A89-9E80-4B1F-8110-8C1959EA7180

P1476

Q35147520-294841DD-EC59-4A56-9A88-B7F82A415030

P2093

Q35147520-000FB354-F296-484B-86EC-F7BA0471ED46

Q35147520-0FF63A84-41B9-465F-B358-896E92491C49

Q35147520-280299D8-702E-48E0-A613-B935134F547A

Q35147520-2828734D-4B0B-4900-AB04-781B67679283

Q35147520-316669EB-7C27-4E90-BE4C-5EC9382DB6B5

Q35147520-3BD49A6B-F1EE-499D-944A-51B4144CAA4B

Q35147520-3CAC18AF-45A8-446E-92AD-A2945A3966FB

Q35147520-53B29545-A91D-45AF-92DB-6C7C5E33E199

Q35147520-560A4BA8-B758-42AB-96E6-A89A91B38F04

Q35147520-6BDC591B-0160-4848-93ED-21A7581D3F19

P2860

Q35147520-120020A2-FB87-4E22-8276-3DFC7ECE78A3

Q35147520-1ED29C4D-438D-44DB-BE6A-991D60C4DCE6

Q35147520-2D0C70B3-7BB5-42BA-885F-AC34680BA109

Q35147520-3B6A0F6A-A3FF-4744-A740-521ABF2235A6

Q35147520-4042794B-03C1-4085-BE65-05082CB8A533

Q35147520-667F7DB3-1906-48F6-AD09-845C187CD5C1

Q35147520-76E8EFF0-623C-46FE-B24B-5AC39DC632A6

Q35147520-8C6A835F-5DF4-41E3-ADC4-129ACFE06E6C

Q35147520-91F956AB-DF81-4409-ACAB-F06125553809

Q35147520-9E648445-ED08-4D16-9AA0-E87C9B3FEB6B

P304

Q35147520-74D2E907-B3DF-4402-9587-B766207C5EEE

P31

Q35147520-D8A46070-4F82-49FA-884C-CB0F4AFDE9C3

P356

Q35147520-1E53CA62-8ACF-4B70-9079-95134295820F

P407

Q35147520-2BEC25FF-F193-4DC0-BBD3-07273E85B944

P433

Q35147520-1E5EC5CC-C18E-41F7-B92C-17420E8BA361

P478

Q35147520-0D353AFA-0A1C-48C1-A688-9941F867A738

P50

Q35147520-671AA950-176B-474F-A167-AC81F55E98C6

Q35147520-891EEAF5-5537-407A-8931-6BC9B1D1D0DE

Q35147520-AA36B81C-7FE4-47AC-88F8-0599768190AA

P577

Q35147520-FC9E1820-47F1-4F8A-8BA9-373FAFE353F7

P698

Q35147520-E91AB340-2069-4A01-87C5-25CBEB67B559

P932

Q35147520-D9ACFEA3-691F-4929-9553-184C89EA4B3A

P356

SLA.0000000000000867

P1433

Annals of Surgery

P1476

Radiological and surgical impl ...... e resectable pancreatic cancer

@en

P2093

Andrew L Warshaw

http://www.w3.org/2001/XMLSchema#string

Andrew X Zhu

http://www.w3.org/2001/XMLSchema#string

Carlos Fernández-del Castillo

http://www.w3.org/2001/XMLSchema#string

Cristina R Ferrone

http://www.w3.org/2001/XMLSchema#string

Daniela Dias Santos

http://www.w3.org/2001/XMLSchema#string

David P Ryan

http://www.w3.org/2001/XMLSchema#string

Erin I McDonnell

http://www.w3.org/2001/XMLSchema#string

Eunice L Kwak

http://www.w3.org/2001/XMLSchema#string

Janet E Murphy

http://www.w3.org/2001/XMLSchema#string

Jason E Faris

http://www.w3.org/2001/XMLSchema#string

P2860

Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages

FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experience

Management of borderline and locally advanced pancreatic cancer: where do we stand?

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

Pancreatic cancer

Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey

Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma.

Pancreatic ductal adenocarcinoma: long-term survival does not equal cure

Neoadjuvant FOLFIRINOX for borderline resectable pancreas cancer: a new treatment paradigm?

P304

12-17

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/SLA.0000000000000867

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

261

http://www.w3.org/2001/XMLSchema#string

P50

Francesco Sabbatino

Giovanni Marchegiani

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25599322

http://www.w3.org/2001/XMLSchema#string

P932

4349683

http://www.w3.org/2001/XMLSchema#string